Catapult Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia (NCT04704323) | Catapult Therapeutics | 2021-09-10 |
Track Catapult Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.